Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 41 (ZNF41) is a transcription factor characterized by multiple C2H2 zinc finger DNA binding motifs and classic KRAB domains (KRAB-A and KRAB-B) that act as transcriptional repressors[1][2]. ZNF41 participates in the regulation of gene expression, likely through recognition of specific DNA sequences using its zinc finger motifs, and its KRAB domains serve to recruit corepressors, contributing to the silencing of target genes. ZNF41 is part of a gene cluster on chromosome Xp11.23 and shows alternative splicing, although the full-length nature of all its transcript variants is not fully understood[1]. KRAB-type zinc finger proteins play essential roles in cellular differentiation, transcriptional regulation, and chromatin remodeling, but ZNF41 itself is mainly discussed in research as a transcription factor, with rare disease associations (e.g., X-linked mental retardation syndromes). Despite the zinc finger family's general involvement in disease processes like cancer and developmental syndromes[3][2], there are no drugs or specific clinical targeting approaches described for ZNF41 at present. Its functions and importance are inferred primarily from its molecular family and structural motifs rather than direct experimental evidence[1][2][3][4].
Not applicable. No mechanism of action for drugs is described for this protein, as it is not an established therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 41 (ZNF41).